Patents by Inventor James T. Harvey
James T. Harvey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230338590Abstract: Antibodies specific for uPAR and uPA-uPAR complexes in the form of radioconjugates with alpha particle-emitting radionuclides are disclosed as is their use in treating severe respiratory diseases such as severe COVID-19.Type: ApplicationFiled: June 15, 2021Publication date: October 26, 2023Inventors: Andrew P. Mazar, James T. Harvey
-
Publication number: 20220409751Abstract: A targeted radiopharmaceutical of chemical Formula I, below, is disclosed wherein Q+3 is a trivalent radioactive isotope ion; M is a proton (H+), an ammonium ion or an alkali metal ion; āgā is a number that is 1 to about 12; the boxed mAb MNPR-101 represents the chemically-bonded humanized mAb MNPR-101; and Y? is an optional anion present in an amount needed to balance the ionic charge. A pharmaceutical composition that comprises a theranostic effective amount of a Formula I targeted radiopharmaceutical dissolved or dispersed in a pharmaceutically acceptable diluent is also disclosed, as are a method for treating and/or diagnosing a mammalian host having a disease, disorder or condition characterized by undesired angiogenesis, tumor growth and/or tumor metastasis. A targeted pro-radiopharmaceutical construct similar to that of Formula I but without the radioisotope (Formula III) is also contemplated.Type: ApplicationFiled: May 20, 2022Publication date: December 29, 2022Applicants: Northstar Medical Technologies, LLC, Monopar Therapeutics IncInventors: Andrew MAZAR, James T. HARVEY, R. Keith FRANK, Jaime SIMON, Jason ROGERS
-
Publication number: 20220378956Abstract: A targeted radiopharmaceutical comprising a targeting species chemically-bonded to a PCTA-chelated Q+3 trivalent radioactive ion of Formula I is disclosed. Six of R1 through R7 are H and the seventh is a reacted functionality, Z, that forms the chemical bond with the targeting species, T. āgā is a number whose average value is 1 to about 12. X1, X2, and X3, are substituent groups that can coordinate to the Q+3 ion and/or help neutralize the ionic charge. Anion Y? is optionally present to balance the ionic charge. A pharmaceutical composition comprising a theranostic effective amount of a targeted radiopharmaceutical of Formula I in a pharmaceutically acceptable diluent is also contemplated, as are a method for treating and/or diagnosing a mammalian host having a disease, disorder or condition characterized by undesired angiogenesis, tumor growth and/or tumor metastasis.Type: ApplicationFiled: May 20, 2022Publication date: December 1, 2022Applicants: Northstar Medical Technologies LLC, Monopar Therapeutics Inc.Inventors: James T. HARVEY, Andrew MAZAR, R. Keith FRANK, Jaime SIMON, Jason ROGERS
-
Publication number: 20220084707Abstract: A system and method for producing radioisotopes such as molybdenum-99. The system comprises a first accelerator, a second accelerator, a first beamline, a second beamline, and a target. Using a pair of accelerators, beamlines are preferably fired at a target from opposite directions, thereby irradiating the target from both sides. The system can further comprise a target cooling system utilizing gaseous helium, a modular local target shielding comprised of boxes of either metal shot with liquid coolant or steel with concrete, and a hot cell for loading and unloading target disks.Type: ApplicationFiled: August 17, 2021Publication date: March 17, 2022Inventors: James T. Harvey, Rimas S. Milunas, Daniel E. Peltier, Sarah M. Burns, James L. McCarter, Tomas A. Montenegro, Jason M. Schlough, Maxwell J. Brennan, Quintin G. Schiller
-
Patent number: 10211780Abstract: An apparatus includes a first circuit and a second circuit. The first circuit may have a first diode and a second diode connected as anti-parallel diodes and physically adjacent to each other in a substrate. The second circuit may have a third diode and a fourth diode connected as anti-parallel diodes and physically adjacent to each other in the substrate. The first circuit and the second circuit may be configured to mix two input signals to generate an output signal. A polarity of every other physically neighboring diode may be reversed.Type: GrantFiled: January 10, 2017Date of Patent: February 19, 2019Assignee: MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.Inventors: Emmanuelle R. O. Convert, Simon J. Mahon, James T. Harvey
-
Publication number: 20170237399Abstract: An apparatus includes a first circuit and a second circuit. The first circuit may have a first diode and a second diode connected as anti-parallel diodes and physically adjacent to each other in a substrate. The second circuit may have a third diode and a fourth diode connected as anti-parallel diodes and physically adjacent to each other in the substrate. The first circuit and the second circuit may be configured to mix two input signals to generate an output signal. A polarity of every other physically neighboring diode may be reversed.Type: ApplicationFiled: January 10, 2017Publication date: August 17, 2017Inventors: Emmanuelle R.O. Convert, Simon J. Mahon, James T. Harvey
-
Patent number: 9614563Abstract: An apparatus includes a first receiver frequency conversion stage and a second receiver frequency conversion stage. The first receiver frequency conversion stage may be configured to generate at least four first intermediate frequency signals in response to a radio frequency (RF) input signal and respective phases of a first local oscillator signal. The second receiver frequency conversion stage may be configured to generate at least four output signals in response to the at least four first intermediate frequency signals and one or more phases of a second local oscillator signal. Each of the at least four output signals is generated in an independent channel in response to a respective one of the at least four first intermediate frequency signals and a respective one of the one or more phases of the second local oscillator signal.Type: GrantFiled: June 28, 2016Date of Patent: April 4, 2017Assignee: MACOM Technology Solutions Holdings, Inc.Inventors: Simon J. Mahon, James T. Harvey, Emmanuelle R. O. Convert
-
Patent number: 9589949Abstract: An apparatus having a plurality of power pads of an integrated circuit, a plurality of transistors, and one or more diodes is disclosed. Each transistors may have a drain that forms a junction with a conductive layer of the integrated circuit. The diodes may be coupled between two of the power pads. A first portion less than all of an electro-static discharge that passes through a first of the two power pads and the conductive layer may be transferred through a first of the drains in a first of the transistors. A second portion less than all of the electro-static discharge may be transferred sequentially through (a) at least one of the diodes and (b) a second of the drains in a second of the transistors.Type: GrantFiled: October 16, 2014Date of Patent: March 7, 2017Assignee: MACOM Technology Solutions Holdings, Inc.Inventors: James T. Harvey, Simon J. Mahon, Anna Dadello
-
Patent number: 9571035Abstract: An apparatus includes a first circuit and a second circuit. The first circuit may be fabricated in a substrate and generally includes a first diode and a second diode (i) connected as anti-parallel diodes and (ii) physically adjacent to each other in the substrate. The second circuit may be fabricated in the substrate and generally includes a third diode and a fourth diode (i) connected as anti-parallel diodes and (ii) physically adjacent to each other in the substrate. The first circuit and the second circuit may be (a) connected in parallel, (b) physically adjacent to each other in the substrate and (c) configured to mix two input signals to generate an output signal.Type: GrantFiled: February 16, 2016Date of Patent: February 14, 2017Assignee: MACOM Technology Solutions Holdings, Inc.Inventors: Emmanuelle R. O. Convert, Simon J. Mahon, James T. Harvey
-
Publication number: 20160308565Abstract: An apparatus includes a first receiver frequency conversion stage and a second receiver frequency conversion stage. The first receiver frequency conversion stage may be configured to generate at least four first intermediate frequency signals in response to a radio frequency (RF) input signal and respective phases of a first local oscillator signal. The second receiver frequency conversion stage may be configured to generate at least four output signals in response to the at least four first intermediate frequency signals and one or more phases of a second local oscillator signal. Each of the at least four output signals is generated in an independent channel in response to a respective one of the at least four first intermediate frequency signals and a respective one of the one or more phases of the second local oscillator signal.Type: ApplicationFiled: June 28, 2016Publication date: October 20, 2016Inventors: Simon J. Mahon, James T. Harvey, Emmanuelle R.O. Convert
-
Patent number: 9407205Abstract: An apparatus includes a first receiver and a second receiver. The first receiver may be configured to generate a plurality of first intermediate frequency signals in response to a radio frequency (RF) input signal and a first local oscillator signal. The second receiver may be configured to generate a plurality of output signals in response to the first intermediate frequency signals. Each of the output signals is generated in an independent channel in response to a respective one of the first intermediate frequency signals and a respective second local oscillator signal.Type: GrantFiled: December 23, 2014Date of Patent: August 2, 2016Assignee: MACOM Technology Solutions Holdings, Inc.Inventors: Simon J. Mahon, James T. Harvey, Emmanuelle R. O. Convert
-
Publication number: 20160181982Abstract: An apparatus includes a first receiver and a second receiver. The first receiver may be configured to generate a plurality of first intermediate frequency signals in response to a radio frequency (RF) input signal and a first local oscillator signal. The second receiver may be configured to generate a plurality of output signals in response to the first intermediate frequency signals. Each of the output signals is generated in an independent channel in response to a respective one of the first intermediate frequency signals and a respective second local oscillator signal.Type: ApplicationFiled: December 23, 2014Publication date: June 23, 2016Inventors: Simon J. Mahon, James T. Harvey, Emmanuelle R.O. Convert
-
Patent number: 6488859Abstract: A cross-linked water-insoluble ion exchange resin comprised of polymerized monomers having a phenyl ring is disclosed. A contemplated resin contains (i) polymerized phenyl ring-containing monomers having a phosphonic acid ligand linked to the phenyl ring, (ii) about 2 to about 5 millimoles per gram (mmol/g) of phosphorus as phosphonic acid ligands, and (iii) a sufficient amount of a sulfonic acid ligand such that the ratio of mmol/g of phosphonic acid to mmol/g sulfonic acid is up to 3:1. A process for removing polyvalent metal cations from aqueous solution, and a process for removing iron(III) cations from acidic copper(II) cation-containing solutions that utilize the contemplated resin or other resins are disclosed.Type: GrantFiled: May 7, 2001Date of Patent: December 3, 2002Assignees: Arch Development Corp, The University of Tennessee Research CorpInventors: Spiro Alexandratos, Christopher A. Shelley, E. Philip Horwitz, Renato Chiarizia, Michael J. Gula, Sui Xue, James T. Harvey
-
Publication number: 20010052496Abstract: A cross-linked water-insoluble ion exchange resin comprised of polymerized monomers having a phenyl ring is disclosed. A contemplated resin contains (i) polymerized phenyl ring-containing monomers having a phosphonic acid ligand linked to the phenyl ring, (ii) about 2 to about 5 millimoles per gram (mmol/g) of phosphorus as phosphonic acid ligands, and (iii) a sufficient amount of a sulfonic acid ligand such that the ratio of mmol/g of phosphonic acid to mmol/g sulfonic acid is up to 3:1. A process for removing polyvalent metal cations from aqueous solution, and a process for removing iron(III) cations from acidic copper(II) cation-containing solutions that utilize the contemplated resin or other resins are disclosed.Type: ApplicationFiled: May 7, 2001Publication date: December 20, 2001Inventors: Spiro Alexandratos, Christopher A. Shelley, E. Philip Horwitz, Renato Chiarizia, Michael J. Gula, Sui Xue, James T. Harvey
-
Patent number: 6303936Abstract: An extraction-scintillation medium of substantially free-flowing, porous, solid particulate matter having one or more fluors retained within the particulate matter and an extraction agent adsorbed on or bound to the surface of the particulate matter. The medium is capable of extracting one of a selected radionuclide from an aqueous stream and permits transmission of light therethrough, which light is emitted from the one or more fluors in response to radiation absorbed thereby from the selected radionuclide. A sensor system using the extraction-scintillation medium for real-time or near real-time detection of the selected radionuclide is also disclosed.Type: GrantFiled: November 12, 1998Date of Patent: October 16, 2001Assignee: Clemson UniversityInventors: Timothy A. DeVol, Jonathan M. Duffey, James T. Harvey, Joel M. Williamson, David D. Brown, James E. Roane